HFE Gene Iron Metabolism and Inflammation | Decoding Inflammation

By Alberto Rivera, MD · 2026-05-19 · 5 min read

Iron as a Double-Edged Metabolic Essential

Iron is indispensable: it is the cofactor at the heart of hemoglobin, cytochrome P450 enzymes, and the mitochondrial electron transport chain. It is also, in excess, a potent generator of reactive oxygen species. Through the Fenton reaction, free ferrous iron reacts with hydrogen peroxide to produce hydroxyl radical, the most reactive and destructive oxidant in biological chemistry, capable of initiating lipid peroxidation chain reactions that damage cellular membranes, proteins, and DNA with indiscriminate efficiency.

The body's homeostatic mechanisms for preventing iron excess are robust, but they are genomically encoded, and variants in the HFE gene compromise them at the level of iron sensing and absorption regulation.

The C282Y and H63D Variants

HFE encodes a protein that interacts with the transferrin receptor to regulate iron uptake from the gastrointestinal tract. The C282Y variant, rs1800562, produces a protein that cannot form the inhibitory complex with the transferrin receptor, resulting in sustained iron absorption regardless of body iron stores. Homozygous C282Y carriers absorb iron without appropriate feedback regulation and accumulate it in liver, heart, pancreas, and joints over decades.

The H63D variant, rs1799945, has a more moderate functional impact but is highly prevalent. Compound heterozygotes, one C282Y and one H63D allele, show clinically significant iron accumulation at a rate intermediate to C282Y homozygotes.

A 2025 analysis of the UK Biobank confirmed that C282Y homozygotes show elevated serum ferritin and transferrin saturation an average of 20 years before clinical diagnosis, with oxidative stress markers, plasma malondialdehyde and 8-isoprostane, elevated in proportion to iron burden throughout that period.

Iron Overload and the Oxygen Free Radical Crisis

In carriers of HFE variants who also carry reduced antioxidant pathway function, SOD2, GPX1, or NQO1 variants, the pro-oxidant burden of excess iron amplifies an already compromised cellular defense. The Fenton reaction operates continuously, producing hydroxyl radical that overwhelms a glutathione system already running below capacity.

The GENEFLAMMATION protocol identifies HFE genotype as a fundamental pro-oxidant variable that must be mapped before antioxidant therapeutic strategies are designed. The clinical response, therapeutic phlebotomy scheduling, dietary iron management, and antioxidant augmentation calibrated to iron burden, follows directly from the genomic characterization.